The peripheral blood mRNA expression levels of NKAPL in the 152N carriers [n = 20, (2.63 ± 0.82)-fold changes] of EOS patients when compared with that of 152T carriers [n = 20, (1.70 ± 0.56)-fold changes] (p = 0.004) (Figure 1). Here, NKAPL is linked to Blau syndrome.